News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Features Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine Shelley Wood December 10, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Features Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope Caitlin E. Cox June 02, 2020
News Features Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies Shelley Wood May 20, 2020
News Features Cardiology After COVID-19: Physicians Predict Lasting Change Yael L. Maxwell May 20, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features Mixed Messages on COVID-19 Masks: Science Falls Short As Deaths Mount Shelley Wood March 27, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind Todd Neale January 02, 2020